» Articles » PMID: 30995725

Insights into the Molecular Mechanisms of Eg5 Inhibition by (+)-Morelloflavone

Overview
Publisher MDPI
Specialty Chemistry
Date 2019 Apr 19
PMID 30995725
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

(+)-Morelloflavone (MF) is an antitumor biflavonoid that is found in the species. Recently, we reported MF as a novel inhibitor of ATPase and microtubules-gliding activities of the kinesin spindle protein (Eg5) in vitro. Herein, we provide dynamical insights into the inhibitory mechanisms of MF against Eg5, which involves binding of the inhibitor to the loop5/α2/α3 allosteric pocket. Molecular dynamics simulations were carried out for 100 ns on eight complexes: Eg5-Adenosine diphosphate (Eg5-ADP), Eg5-ADP--trityl-l-cysteine (Eg5-ADP-STLC), Eg5-ADP-ispinesib, Eg5-ADP-MF, Eg5-Adenosine triphosphate (Eg5-ATP), Eg5-ATP-STLC, Eg5-ATP-ispinesib, and Eg5-ATP-MF complexes. Structural and energetic analyses were done using Umbrella sampling, Molecular Mechanics Poisson-Boltzmann Surface Area (MM/PBSA) method, GROMACS analysis toolkit, and virtual molecular dynamics (VMD) utilities. The results were compared with those of the known Eg5 inhibitors; ispinesib, and STLC. Our data strongly support a stable Eg5-MF complex, with significantly low binding energy and reduced flexibility of Eg5 in some regions, including loop5 and switch I. Furthermore, the loop5 Trp127 was trapped in a downward position to keep the allosteric pocket of Eg5 in the so-called "closed conformation", comparable to observations for STLC. Altered structural conformations were also visible within various regions of Eg5, including switch I, switch II, α2/α3 helices, and the tubulin-binding region, indicating that MF might induce modifications in the Eg5 structure to compromise its ATP/ADP binding and conversion process as well as its interaction with microtubules. The described mechanisms are crucial for understanding Eg5 inhibition by MF.

Citing Articles

Effective Synthesis and Biological Evaluation of Natural and Designed Bis(indolyl)methanes via Taurine-Catalyzed Green Approach.

Chavan K, Shukla M, Chauhan A, Maji S, Mali G, Bhattacharyya S ACS Omega. 2022; 7(12):10438-10446.

PMID: 35382311 PMC: 8973083. DOI: 10.1021/acsomega.1c07258.


Integrated Machine Learning and Chemoinformatics-Based Screening of Mycotic Compounds against Kinesin Spindle ProteinEg5 for Lung Cancer Therapy.

Maiti P, Sharma P, Nand M, Bhatt I, Ramakrishnan M, Mathpal S Molecules. 2022; 27(5).

PMID: 35268740 PMC: 8911701. DOI: 10.3390/molecules27051639.


Recent Developments in Free Energy Calculations for Drug Discovery.

King E, Aitchison E, Li H, Luo R Front Mol Biosci. 2021; 8:712085.

PMID: 34458321 PMC: 8387144. DOI: 10.3389/fmolb.2021.712085.

References
1.
Endow S . Microtubule motors in spindle and chromosome motility. Eur J Biochem. 1999; 262(1):12-8. DOI: 10.1046/j.1432-1327.1999.00339.x. View

2.
Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

3.
Kapoor T, Mayer T, Coughlin M, Mitchison T . Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. J Cell Biol. 2000; 150(5):975-88. PMC: 2175262. DOI: 10.1083/jcb.150.5.975. View

4.
Farrell C, Mackey A, Klumpp L, Gilbert S . The role of ATP hydrolysis for kinesin processivity. J Biol Chem. 2002; 277(19):17079-87. DOI: 10.1074/jbc.M108793200. View

5.
Jakalian A, Jack D, Bayly C . Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem. 2002; 23(16):1623-41. DOI: 10.1002/jcc.10128. View